60 related articles for article (PubMed ID: 38745323)
1. The impact of an innovative payment method on medical expenditure, efficiency, and quality for inpatients with different types of medical insurance: evidence from a pilot city, China.
Lin K; Li Y; Yao Y; Xiong Y; Xiang L
Int J Equity Health; 2024 Jun; 23(1):115. PubMed ID: 38840102
[TBL] [Abstract][Full Text] [Related]
2. Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis.
Zhang L; Wang X; Yao H; Ding B; Gao X; Li X
Int J Equity Health; 2024 Jun; 23(1):116. PubMed ID: 38840134
[TBL] [Abstract][Full Text] [Related]
3. How does diagnosis-related group payment impact the health care received by rural residents? Lessons learned from China.
Xiang X; Dong L; Qi M; Wang H
Public Health; 2024 Jul; 232():68-73. PubMed ID: 38749150
[TBL] [Abstract][Full Text] [Related]
4. Time trends and regional variations in prices of anticancer medicines in China.
Zhang J; Hu S; Liu X; Liu X; Zhang J; Yang C; Fang Y
Front Pharmacol; 2024; 15():1397784. PubMed ID: 38813105
[TBL] [Abstract][Full Text] [Related]
5. The development of day surgery in China and the effectiveness and reflection of day surgery in ophthalmology-specialized hospitals.
Haihan D; Changfei Z; Hengli L; Ning T; Lezhen Z; Hui L
Cost Eff Resour Alloc; 2024 May; 22(1):47. PubMed ID: 38802948
[TBL] [Abstract][Full Text] [Related]
6. Contested Issues of Efficacy and Safety between Transnational Formulation Regimes of Tibetan Medicines in China and Europe.
Schrempf M
Asian Med (Leiden); 2015; 10(1-2):273-315. PubMed ID: 27885323
[TBL] [Abstract][Full Text] [Related]
7. Reducing the medical economic burden of health insurance in China: Achievements and challenges.
Dou G; Wang Q; Ying X
Biosci Trends; 2018 Jul; 12(3):215-219. PubMed ID: 29925702
[TBL] [Abstract][Full Text] [Related]
8. The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.
Li BX; Wang YQ; Yi YY; Zhou N; Lv ZX; Ma R; Li X; Yuan N
BMC Public Health; 2024 May; 24(1):1309. PubMed ID: 38745323
[TBL] [Abstract][Full Text] [Related]
9. Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China.
Mingge X; Jingyu W; Qi L; Zhe Z; Qing R
Inquiry; 2023; 60():469580231170729. PubMed ID: 37171066
[TBL] [Abstract][Full Text] [Related]
10. The influence of the national drug price negotiation policy reform on the medical expenses of patients in Xuzhou City: an interrupted time series analysis.
Qin Z; He M; Shen H; Liu S; Xu S; Chen L
Front Public Health; 2024; 12():1381786. PubMed ID: 38903594
[TBL] [Abstract][Full Text] [Related]
11. The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data.
Yang Y; Zhang Y; Wagner AK; Li H; Shi L; Guan X
J Glob Health; 2023 Aug; 13():04083. PubMed ID: 37566690
[TBL] [Abstract][Full Text] [Related]
12. Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study.
Cai L; Tao T; Li H; Zhang Z; Zhang L; Li X
J Glob Health; 2022 Dec; 12():11016. PubMed ID: 36527382
[TBL] [Abstract][Full Text] [Related]
13. Access to innovative anticancer medicines in China: a national survey on availability, price and affordability.
Li W; Lu W; Chen H; Zhang C; Wang M; Zheng F; Wu HH; Wan GW; Yang Q; Ye L
BMJ Open; 2024 Apr; 14(4):e077089. PubMed ID: 38670605
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
